Recent Posts
- Philochem AG announces Board of Appeal decision on Philochem’s Patent on Production of Encoded Chemical Libraries
- Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma
- Philochem AG (a company of the Philogen group) announces the completion of central radiolabeling activities for the therapeutic use of OncoFAP-23
- Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors
- Philogen announces new publication in Nature Chemistry
Recent Comments